Top Eminent Healthcare Group (6877) Fair Value & Analysis
Financial Services · HK · Market cap HK$209M
Fair value as of: Aug 6, 2026
From 1 valuation models · updated 4 days ago
Fair value updated Aug 6, 2026, revised from HK$0.1100 to HK$0.1074 (−2.4%) since Jul 2, 2026. Share price +4.0% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (HK$0.0722 to HK$0.1338) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.
How to read this chart
60‑month range HK$0.0510 – HK$0.5100 · fair‑value band HK$0.0722 – HK$0.1338 · the HK$0.1040 price screens below the HK$0.1074 fair value. Dashed = 300-day average. As of Aug 6, 2026.
Analysis
Top Eminent Healthcare Group (6877) currently trades at HK$0.1040, while our model-based Fair Value estimate is HK$0.1074, implying the stock looks roughly 3.3% fairly valued today. The Quality Score stands at 55/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Top Eminent Healthcare Group generated revenue of HK$110M at a net margin of -6.5%. Revenue grew 60.5% year over year. It earns a return on equity of -2.9%. The balance sheet holds a net cash position of HK$208M. Fundamentals as of Aug 6, 2026
Our scenario range runs from HK$0.0722 (bear case) to HK$0.1338 (bull case); at HK$0.1040, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 71% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 11% fair-value upside, at 3%, 6877 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 6877 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 5
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Top Eminent Healthcare Group Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. It operates through the healthcare business and unallocated segment segments. The company also provides molecular tea, Ganoderma lucidum, brain protection capsules, and natural factors.
Full company description
Top Eminent Healthcare Group Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. It operates through the healthcare business and unallocated segment segments. The company also provides molecular tea, Ganoderma lucidum, brain protection capsules, and natural factors. Top Eminent Healthcare Group Limited was formerly known as CLSA Premium Limited and changed its name to Top Eminent Healthcare Group Limited in May 2025. Top Eminent Healthcare Group Limited was incorporated in 2010 and is headquartered in Wan Chai, Hong Kong. As of April 1, 2025, Top Eminent Healthcare Group Limited operates as a subsidiary of Beijing Tong Ren Tang (Cayman) Limited.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Top Eminent Healthcare Group reported revenue of HK$110M in FY2025 versus HK$5.4M in FY2021, a compound +112.0%/yr. Reported net income was −HK$7.1M in FY2025.
Watch 6877: get an alert when its fair value changes →
Peer Group
Capital Markets · 423 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Capital Markets median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Huatai Securities Co HTSC | $0.2700 | $0.0400 | -85% |
| Mirae Asset Securities Co 006800 | 38,750 KRW | 31,645 KRW | -18% |
| Meritz Financial Group 138040 | 117,000 KRW | 87,706 KRW | -25% |
| Korea Investment Holdings 071050 | 239,000 KRW | 318,825 KRW | +33% |
| NH Investment & Securities Co 005940 | 31,000 KRW | 37,133 KRW | +20% |
| Samsung Securities Co 016360 | 107,700 KRW | 126,487 KRW | +17% |
| Motilal Oswal Financial Services Limited MOTILALOFS | ₹967.00 | ₹299.65 | -69% |
| Kiwoom Securities Co 039490 | 322,000 KRW | 358,091 KRW | +11% |
| SSI Securities Corporation SSI | 24,250 VND | 28,021 VND | +16% |
| Bolsas y Mercados Argentinos S.A BYMA | 313.75 ARS | 120.22 ARS | -62% |
Compare Top Eminent Healthcare Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Top Eminent Healthcare Group (6877) overvalued or undervalued?
What is the fair value of 6877?
What is the quality score of 6877?
What is the revenue of Top Eminent Healthcare Group (6877)?
What is the net profit margin of 6877?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Top Eminent Healthcare Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.